|
Ask for help with limit for Nitroso-olaparib
|
|
2
|
223
|
September 4, 2025
|
|
N-nitroso-omadacycline mutagenic
|
|
3
|
135
|
September 2, 2025
|
|
Why EMA has done read-across for N-nitroso-desmethyl-doxylamine?
|
|
9
|
381
|
September 1, 2025
|
|
Why do nitrosamine impurities of omacycline and tigecycline have different AI values?
|
|
8
|
362
|
August 28, 2025
|
|
Published limit for N-Nitroso-Vonoprazan
|
|
2
|
317
|
August 15, 2025
|
|
N-nitroso-amlodipine ; N-nitroso-felodipine ; synthesis not successfull but still listed by FDA and EMA as NDSRIs
|
|
15
|
4738
|
April 16, 2025
|
|
Lifetime Cumulative Dose and Less Than Lifetime Approach
|
|
3
|
588
|
July 16, 2025
|
|
MEGLUMINE (Methylglucamine)
|
|
27
|
3422
|
July 10, 2025
|
|
Criterios de aceptación
|
|
2
|
117
|
June 26, 2025
|
|
Quantifier and Qualifier Ion in mass spec
|
|
6
|
284
|
June 26, 2025
|
|
Calculation of limit when more than one nitrosamine is identified
|
|
10
|
1311
|
June 19, 2025
|
|
Risk (Re)Assessment of N-Methyl-N-nitrosophenethylamine for use in computing risk levels of N-Nitrosamine Drug Substance Related Impurities
|
|
2
|
236
|
June 18, 2025
|
|
Using N-Nitrosodiethanolamine (NDELA) and N-Nitrosopiperidine (NPIP) Transgenic Rodent Gene Mutation Data and Quantum Mechanical Modeling to Derive Potency-Based Acceptable Intakes for NDSRIs Lacking Robust Carcinogenicity Data-Pub
|
|
0
|
238
|
June 6, 2025
|
|
AI limit for 1-Nitrosopiperazine
|
|
8
|
566
|
June 4, 2025
|
|
Limits for NDMA in Dapagliflozin+Metformin
|
|
19
|
638
|
May 28, 2025
|
|
If only I had known…
|
|
41
|
2273
|
May 23, 2025
|
|
How to set Acceptance criteria for nitrosamines impurities in FDC-FPPs
|
|
1
|
217
|
May 6, 2025
|
|
MDD for Metformin
|
|
4
|
326
|
May 2, 2025
|
|
Risk Assessment ASS/Paracetamol/Coffein tablets
|
|
7
|
757
|
April 29, 2025
|
|
Visualization of Categorized Compounds by CPCA
|
|
67
|
8969
|
April 24, 2025
|
|
N-nitroso-esmolol
|
|
0
|
194
|
April 22, 2025
|
|
⁉️ Duloxetine Impurity NDSRI
|
|
9
|
1068
|
April 22, 2025
|
|
The quagmire with the interim limit of nitroso duloxetine
|
|
6
|
631
|
April 21, 2025
|
|
LTL or not LTL that's the question?
|
|
5
|
468
|
April 15, 2025
|
|
N-Nitroso Caffeidine
|
|
3
|
171
|
April 14, 2025
|
|
Risk mitigation based on DP specifications
|
|
10
|
695
|
April 7, 2025
|
|
Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential -Pub
|
|
8
|
589
|
April 2, 2025
|
|
N-nitrosodicyclohexylamine (NDCHA), what do you know about it?
|
|
18
|
607
|
March 21, 2025
|
|
AI limits and CPCA score (O=NN1CCN=C1CCl)
|
|
8
|
444
|
March 17, 2025
|
|
Draft guidance on the use of read across for chemical safety assessment in food and feed(EFSA)
|
|
0
|
274
|
March 16, 2025
|